| __timestamp | Alpine Immune Sciences, Inc. | Incyte Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 12199547 | 347523000 |
| Thursday, January 1, 2015 | 16054000 | 479514000 |
| Friday, January 1, 2016 | 23316000 | 581861000 |
| Sunday, January 1, 2017 | 10626000 | 1326361000 |
| Monday, January 1, 2018 | 28970000 | 1197957000 |
| Tuesday, January 1, 2019 | 35847000 | 1154111000 |
| Wednesday, January 1, 2020 | 27185000 | 2215942000 |
| Friday, January 1, 2021 | 58742000 | 1458179000 |
| Saturday, January 1, 2022 | 70243000 | 1585936000 |
| Sunday, January 1, 2023 | 80904000 | 1627594000 |
| Monday, January 1, 2024 | 2606848000 |
Data in motion
In the competitive world of biotechnology, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Incyte Corporation and Alpine Immune Sciences, Inc. have demonstrated contrasting approaches to R&D investment. Incyte, a leader in the field, has consistently allocated substantial resources, with a peak in 2020 when R&D expenses reached nearly $2.2 billion. This represents a staggering 536% increase from 2014. Meanwhile, Alpine Immune Sciences, a smaller player, has shown a steady growth in R&D spending, culminating in an 86% rise from 2014 to 2023. This strategic allocation reflects their focus on pioneering immune-based therapies. As the biotech landscape evolves, these investments underscore the companies' dedication to advancing medical breakthroughs and maintaining a competitive edge.
R&D Insights: How Vertex Pharmaceuticals Incorporated and Alpine Immune Sciences, Inc. Allocate Funds
R&D Insights: How Takeda Pharmaceutical Company Limited and Alpine Immune Sciences, Inc. Allocate Funds
Comparing Innovation Spending: argenx SE and Alpine Immune Sciences, Inc.
Analyzing R&D Budgets: Genmab A/S vs Incyte Corporation
Research and Development Expenses Breakdown: Incyte Corporation vs Ascendis Pharma A/S
Incyte Corporation vs Viking Therapeutics, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Incyte Corporation and Veracyte, Inc.
Incyte Corporation or HUTCHMED (China) Limited: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Incyte Corporation and Viridian Therapeutics, Inc.
Comparing Innovation Spending: Lantheus Holdings, Inc. and Alpine Immune Sciences, Inc.
Alkermes plc or Alpine Immune Sciences, Inc.: Who Invests More in Innovation?
Alpine Immune Sciences, Inc. or Catalyst Pharmaceuticals, Inc.: Who Invests More in Innovation?